Minister Bibeau announces reappointment to the Farm Products Council of Canada

May 05, 2021

Ottawa, Ontario – Agriculture and Agri-Food Canada

The Honourable Marie-Claude Bibeau, Minister of Agriculture and Agri-Food, announced the reappointment of Maryse Dubé to the Farm Products Council of Canada (FPCC) for a four-year term, effective April 30, 2021.

Ms. Dubé was first appointed to the FPCC in 2015, and was later reappointed in 2018. She has been working in commercial and food law representing several financial institutions since 2004, and also represents small and medium-sized enterprises in commercial litigation and securities, bankruptcy and corporate law (manufacturing and agricultural components). Ms. Dubé has served on a number of corporate and community boards in the Maskoutain region, in addition to speaking at various conferences. She also teaches at the Barreau du Québec (Montréal).

In 2016, the Government of Canada implemented an open, transparent and merit-based process for selecting Governor in Council appointees. Appointees play a fundamental role in Canada’s democracy by serving on commissions, boards, Crown corporations, agencies and tribunals across the country.

Source : Government of Canada

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.